v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues:    
Revenues $ 2,062 $ 3,108
Cost of revenues:    
Cost of revenues 26 116
Gross margin 2,036 2,992
Operating expenses:    
Research and development 3,779 3,444
Sales and marketing 2,274 2,328
General and administrative 4,123 3,767
Total operating expenses 10,176 9,539
Gain from patent assignment 19,389 0
Broker fee from patent assignment (3,878) 0
Operating income (loss) 7,371 (6,547)
Other income, net 657 687
Income (loss) before provision (benefit) for income taxes (8,028) 5,860
Provision (benefit) for income taxes (9) 15
Income (loss) from continuing operations 8,037 (5,875)
Income (loss) from discontinued operations 456 (591)
Net income (loss) $ 8,493 $ (6,466)
Income (loss) per common share:    
Basic and diluted income (loss) per share from continuing operations (in dollars per share) $ 0.48 $ (0.37)
Basic and diluted income (loss) per share from discontinued operations (in dollars per share) 0.03 (0.04)
Basic and diluted net income (loss) per share(a) (in dollars per share) $ 0.51 $ (0.41)
Basic and diluted – weighted average number of common shares outstanding (in shares) 16,783 15,873
License Fees [Member]    
Revenues:    
Revenues $ 1,822 $ 2,687
Non-recurring Engineering [Member]    
Revenues:    
Revenues 240 421
Cost of revenues:    
Cost of revenues $ 26 $ 116